• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconFDA

FDA

Page 4 of 36
The outside of the FDA headquarters
Politics
FDA scrambles to rehire entire teams overseeing medical devices after DOGE cut them, saying their terminations are ‘rescinded effective immediately’
By Matthew Perrone and The Associated PressFebruary 24, 2025
Semaglutide medications Wegovy and Ozempic are pictured
Health
Wegovy, Ozempic shortage declared over, hitting copycats like Hims & Hers
By Bloomberg, Madison Muller, Ike Swetlitz and Naomi KresgeFebruary 21, 2025
A woman takes pills at her desk
Health
The dietary supplements you think are improving your health may be damaging your liver, research warns
By Lindsey LeakeFebruary 18, 2025
Trump administration cuts reach FDA employees in food safety, medical devices and tobacco products
Health
Trump administration cuts reach FDA employees in food safety, medical devices and tobacco products
By Matthew Perrone and The Associated PressFebruary 16, 2025
A woman holds a medicine bottle while reading instructions.
Health
Gen Z’s expensive drug habit: More want brand-name meds that are 79% more expensive
By Lindsey LeakeFebruary 14, 2025
Doctor analyzes health care data
Health
Judge tells CDC, FDA to restore webpages and data removed after Trump’s executive order
By The Associated Press and Michael KunzelmanFebruary 11, 2025
A woman injects herself with medication.
Health
Ozempic, Wegovy maker calls out Hims & Hers Super Bowl ad: ‘Check before you inject’
By Lindsey LeakeFebruary 11, 2025
A young woman undergoes a brain scan.
Health
Meet the 24-year-old helping Lilly test a preventive Alzheimer’s drug
By Lindsey LeakeFebruary 6, 2025
A person stands on a scale.
Health
Hims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs
By Lindsey LeakeFebruary 3, 2025
Close-up view of man in blue button-down shirt placing pills in his hand.
Health
New pain drug, Vertex’s Journavx, gets FDA approval as safer alternative to addictive opioids
By Bloomberg and Gerry SmithJanuary 31, 2025
The increase in online searches for obesity management drugs in recent years correlated to a surge in dispensed prescriptions, according to a new study from the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease.
Health
Online searches predicted the surge in prescriptions of weight-loss drugs like Wegovy and Zepbound, study says. Here’s what could happen next
By Lindsey LeakeJanuary 29, 2025
Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication in the works that could be approved by the FDA as early as 2026, CEO Dave Ricks told Bloomberg TV on Jan. 13, 2025.
Health
Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says
By Lindsey LeakeJanuary 21, 2025
woman pouring milk from one container into another outside, with a cow in the background
Health
Raw milk, touted by RFK Jr. and costing up to $21 a gallon, is under fire because of bird flu. What science says about the benefits and risks
By Beth GreenfieldJanuary 17, 2025
A pile of candy hearts with messages written on them for Valentine's Day
Health
What foods have Red dye 3? Candy Corn, red icing, and other favorite snacks
By The Associated Press and Hallie SteinerJanuary 16, 2025
FDA bans red dye No. 3 from foods, supplements, and some medicines because of potential cancer risk
Health
FDA bans red dye No. 3 from foods, supplements, and some medicines because of potential cancer risk
By The Associated PressJanuary 15, 2025
1
  • 2
  • 3
  • 4
  • 5
  • 6
...36
Most Popular
Law
Egg companies made $1.22 billion in profit off a $6 carton — now they’re buying their way out of a price-fixing case with 53 million donated eggsplaceholder alt text
By Wyatte Grantham-Philips and The Associated PressJuly 2, 2026
AI
Meet the Zillennials: The luckiest micro-generation in the workforce, born between 1993 and 1998placeholder alt text
By Nick LichtenbergJuly 3, 2026
Economy
Economists have found an answer to slowing cognitive decline: Avoid retiring early, study findsplaceholder alt text
By Sasha RogelbergJuly 2, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.